Issued Patents All Time
Showing 26–50 of 338 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11912695 | Benzodiazepine derivatives as RSV inhibitors | Kaicheng Zhu, Kevin McGrath, Solymar Negretti-Emmanuelli, Adam Szymaniak, Jianming Yu +1 more | 2024-02-27 |
| 11891393 | Functionalized heterocycles as antiviral agents | Joseph Panarese, Dexter Davis, Samuel Bartlett, Katherine Chong, Nathaniel Thomas Kenton | 2024-02-06 |
| 11858945 | Alkyne-containing antiviral agents | Joseph Panarese, Samuel Bartlett, Guoqiang Wang | 2024-01-02 |
| 11834436 | Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Guoqiang Wang, Ruichao Shen, Brett Granger, Jing He, Xuechao Xing +4 more | 2023-12-05 |
| 11802125 | Functionalized heterocyclic compounds as antiviral agents | Joseph Panarese, Dexter Davis, Nathaniel Thomas Kenton, Samuel Bartlett | 2023-10-31 |
| 11760755 | Hepatitis B antiviral agents | Yao-Ling Qiu, Xiaowen Peng, Xuri Gao, Wei Li, Hui Cao +3 more | 2023-09-19 |
| 11753403 | EIF4E inhibitors and uses thereof | Christopher L. VANDEUSEN, Alan E. Walts | 2023-09-12 |
| 11738019 | Substituted heterocycles as antiviral agents | Joseph Panarese, Samuel Bartlett, Dexter Davis, Nathaniel Thomas Kenton | 2023-08-29 |
| 11718641 | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | Guoqiang Wang, Ruichao Shen, Jiang Long, Peng Dai, Xuechao Xing +1 more | 2023-08-08 |
| 11596611 | Hepatitis B antiviral agents | Yao-Ling Qiu, Xuri Gao, Jorden Kass, Hui Cao, Wei Li +2 more | 2023-03-07 |
| 11578097 | Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof | Jing He, Guoqiang Wang | 2023-02-14 |
| 11572367 | Antiviral heterocyclic compounds | Adam Szymaniak, Kevin McGrath, Jianming Yu, Tyler Mann, Long Nguyen +2 more | 2023-02-07 |
| 11560368 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Guoqiang Wang, Ruichao Shen, Jiang Long, Jun Ma, Xuechao Xing +4 more | 2023-01-24 |
| 11555032 | Isoxazole derivatives as FXR agonists and methods of use thereof | Guoqiang Wang, Jun Ma, Bin Wang, Ruichao Shen, Xuechao Xing +1 more | 2023-01-17 |
| 11534439 | Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors | Jianming Yu, In Jong Kim | 2022-12-27 |
| 11505558 | Antiviral heterocyclic compounds | Adam Szymaniak, Kevin McGrath, Jianming Yu, Tyler Mann, Long Nguyen +2 more | 2022-11-22 |
| 11472808 | Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents | Yao-Ling Qiu, Xiaowen Peng, Wei Li, Xuri Gao, Jorden Kass +3 more | 2022-10-18 |
| 11466033 | Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors | Brett Granger, Yong He, Guoqiang Wang | 2022-10-11 |
| 11420976 | Heterocyclic compounds as anti-viral agents | Yong He, Xuechao Xing, Guoqiang Wang, Ruichao Shen, Brett Granger +1 more | 2022-08-23 |
| 11390631 | Benzodiazepine derivatives as RSV inhibitors | Brian C. Shook, In Jong Kim, Thomas P. Blaisdell, Jianming Yu, Joseph Panarese | 2022-07-19 |
| 11384090 | Spiropyrrolidine derived antiviral agents | Guoqiang Wang, Ruichao Shen, Yong He, Xuri Gao, Jun Ma +3 more | 2022-07-12 |
| 11377450 | Functionalized heterocycles as antiviral agents | Joseph Panarese, Samuel Bartlett, Dexter Davis, Katherine Chong | 2022-07-05 |
| 11358953 | Functionalized peptides as antiviral agents | Joseph Panarese, Dexter Davis, Nathaniel Thomas Kenton, Samuel Bartlett, Sean M. Rafferty | 2022-06-14 |
| 11352363 | Spiropyrrolidine derived antiviral agents | Guoqiang Wang, Xuri Gao, Ruichao Shen, Yong He, Jiajun Zhang +3 more | 2022-06-07 |
| 11345699 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Brett Granger, Guoqiang Wang, Ruichao Shen, Jing He, Yong He +4 more | 2022-05-31 |